Assessing 15 Proposals for Promoting Innovation and Access to Medicines Globally
<p>Background</p><p>There is widespread recognition that the existing global systems for innovation and access to medicines need reform. Billions of people do not have access to the medicines they need, and market failures prevent new drugs from being developed for diseases that pr...
Saved in:
Main Authors: | Steven J. Hoffman, Karen So |
---|---|
Format: | article |
Language: | EN |
Published: |
Ubiquity Press
2015
|
Subjects: | |
Online Access: | https://doaj.org/article/b0f2d6b36cd045649807476acaa1f77c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
From Imitation to Innovation: A Study of China's Drug R&D and Relevant National Policies
by: Ding,Jingxi, et al.
Published: (2011) -
Access to medicines and incentives for innovation: The balance struck in the Trans-Pacific Partnership (TPP) on intellectual property (patent and data exclusivity) protection for pharmaceutical products
by: Artecona, Raquel, et al.
Published: (2016) -
Innovation Trends in NAFTA Countries: an Econometric Analysis of Patent Applications
by: Rodríguez,José Carlos, et al.
Published: (2011) -
Medicamentos esenciales y propiedad intelectual : análisis para países en desarrollo /
by: Parra Salas, Luis Edgar
Published: (2012) -
Patent Applications on Representative Sectors of Biotechnology in Brazil: an Analysis of the Last Decade
by: Mendes,Liliana, et al.
Published: (2013)